Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
321 Gang is a US-based consultancy specializing in systems/software engineering process improvement for organizations developing large-scale or mission-critical systems—especially those operating under strict regulatory requirements such as aerospace & defense or medical devices. The company does not develop drugs or biologics but supports life science companies with compliance-focused software/process solutions. In August 2023 it was acquired by the European-headquartered SodiusWillert Group to expand its reach in North America and Europe. Its core offerings include Lean Agile transformation using SAFe®, model-based systems engineering implementation/training/support for IBM Rational products/GitLab/etc., requirements management solutions for regulated industries including medtech. If you are seeking information about a life sciences R&D/development-stage company named "321 Gang," there is no evidence such an entity exists based on current data—the above profile matches the only known "321 Gang."
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 321 Gang.